Etomidate


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000138 Acidosis PMID:7477798; PMID:9322462
MESH:D000309 Adrenal Insufficiency PMID:19092649; PMID:7477798
MESH:D000799 Angioedema PMID:3578739
MESH:D001049 Apnea PMID:20912; PMID:3344940; PMID:4025853
MESH:D001919 Bradycardia PMID:2892519; PMID:3919609
MESH:D002534 Hypoxia, Brain PMID:9322462
MESH:D002545 Brain Ischemia PMID:8559304
MESH:D004830 Epilepsy, Tonic-Clonic PMID:20803863
MESH:D004890 Erythema PMID:1015219; PMID:6743462
MESH:D006323 Heart Arrest PMID:6362477
MESH:D006456 Hemoglobinuria PMID:7898032; PMID:8563446
MESH:D006461 Hemolysis PMID:7898032; PMID:8559304; PMID:8563446
MESH:D006973 Hypertension PMID:3618996
MESH:D007022 Hypotension PMID:10698137; PMID:15295727; PMID:15496697; PMID:2207824; PMID:9796607
MESH:D007035 Hypothermia PMID:7898032
MESH:D008569 Memory Disorders PMID:16597725
MESH:D009127 Muscle Rigidity PMID:3919609
MESH:D009207 Myoclonus PMID:1015219; PMID:1015239; PMID:10513376; PMID:12635389; PMID:12694150; PMID:14652121; PMID:14655236; PMID:15167427; PMID:15295244; PMID:16115978; PMID:16548978; PMID:16563323; PMID:16914464; PMID:16997421; PMID:16997680; PMID:17005362; PMID:17471876; PMID:17959958; PMID:18230263; PMID:19100933; PMID:20018300; PMID:20108006; PMID:2207824; PMID:24535067; PMID:3354919; PMID:3621016; PMID:3752481; PMID:3966657; PMID:4025853; PMID:4025859; PMID:4083468; PMID:526383; PMID:612112; PMID:6148025; PMID:6322557; PMID:6696228; PMID:7027723; PMID:8214699; PMID:9915320
MESH:D009325 Nausea PMID:7457821
MESH:D010146 Pain PMID:1015218; PMID:1015219; PMID:1015239; PMID:10655920; PMID:16997680; PMID:21056806; PMID:2178488; PMID:2278365; PMID:339773; PMID:4025853; PMID:526382; PMID:526383; PMID:612112; PMID:6148025; PMID:6322557; PMID:6650800; PMID:6691878; PMID:6743462; PMID:7457821
MESH:D010689 Phlebitis PMID:6108669
MESH:D011595 Psychomotor Agitation PMID:7546752
MESH:D011618 Psychotic Disorders PMID:7457821
MESH:D012140 Respiratory Tract Diseases PMID:7457821
MESH:D012640 Seizures PMID:11116789; PMID:17804993; PMID:3177871; PMID:4083468; PMID:6136664
MESH:D013924 Thrombophlebitis PMID:2178488; PMID:2278365; PMID:2675669; PMID:6108669; PMID:6691878
MESH:D013927 Thrombosis PMID:2278365; PMID:6108669
MESH:D014202 Tremor PMID:3344940
MESH:D014581 Urticaria PMID:2675669
MESH:D014652 Vascular Diseases PMID:10655920
MESH:D014693 Ventricular Fibrillation PMID:18334037
MESH:D014839 Vomiting PMID:7457821; PMID:7546752
MESH:D017180 Tachycardia, Ventricular PMID:17457141; PMID:18334037
MESH:D017202 Myocardial Ischemia PMID:6362477
MESH:D018376 Cardiovascular Abnormalities PMID:2742101
MESH:D020250 Postoperative Nausea and Vomiting PMID:3919609; PMID:4025853
MESH:D020820 Dyskinesias PMID:20912; PMID:526382
MESH:D051437 Renal Insufficiency PMID:7477798
MESH:D054537 Atrioventricular Block PMID:18210663
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:8563446

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.